Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
Article in Frontiers in Neurology (July 2019)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study
Article in Multiple Sclerosis and Related Disorders (February 2019)
Multiple sclerosis - escalation therapies and evidence-based medicine
Article in Neurologie pro praxi (December 2017)